Accessibility Menu
Eastwood Bio-Medical Canada logo

Eastwood Bio-Medical Canada

(TSXV) EBM

Current PriceCA$0.77
Market CapCA$48.22M
Since IPO (2014)+75%
5 Year-65%
1 Year+75%
1 Month+8%

Eastwood Bio-Medical Canada Financials at a Glance

Market Cap

CA$48.22M

Revenue (TTM)

CA$719.58K

Net Income (TTM)

-CA$312.31K

EPS (TTM)

-CA$0.00

P/E Ratio

-155.56

Dividend

CA$0.00

Beta (Volatility)

0.61 (Low)

Price

CA$0.77

Volume

2,070

Open

CA$0.77

Previous Close

CA$0.77

Daily Range

CA$0.77 - CA$0.77

52-Week Range

CA$0.30 - CA$1.10

EBM News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Eastwood Bio-Medical Canada

Industry

Healthcare Providers and Services

CEO

Youngsoo Kim, PhD

Headquarters

Richmond, BC V6X 3Z6, CA

EBM Financials

Key Financial Metrics (TTM)

Gross Margin

63%

Operating Margin

-58%

Net Income Margin

-63%

Return on Equity

0%

Return on Capital

60%

Return on Assets

-1%

Earnings Yield

-0.64%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

CA$48.22M

Shares Outstanding

68.89M

Volume

2.07K

Avg. Volume

3.73K

Financials (TTM)

Gross Profit

CA$506.03K

Operating Income

-CA$354.70K

EBITDA

-CA$309.73K

Operating Cash Flow

CA$19.30K

Capital Expenditure

-CA$3.00

Free Cash Flow

CA$19.30K

Cash & ST Invst.

CA$17.70K

Total Debt

CA$78.01K

Eastwood Bio-Medical Canada Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

CA$152.22K

-29.1%

Gross Profit

CA$93.72K

-41.1%

Gross Margin

61.57%

N/A

Market Cap

CA$48.22M

N/A

Market Cap/Employee

N/A

N/A

Employees

N/A

N/A

Net Income

-CA$20.73K

+49.7%

EBITDA

-CA$30.00K

-728.4%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Net Cash

-CA$61.21K

+17.4%

Accounts Receivable

CA$61.29K

+592.4%

Inventory

CA$0.00

N/A

Long Term Debt

CA$0.00

N/A

Short Term Debt

CA$74.67K

-9.8%

Return on Assets

-1.12%

N/A

Return on Invested Capital

60.09%

N/A

Free Cash Flow

-CA$900.00

-121.9%

Operating Cash Flow

-CA$900.00

-121.9%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
SWP.TOSwiss Water Decaffeinated Coffee Inc.
CA$5.78+1.40%
BU.TOBurcon NutraScience Corporation
CA$1.94+1.04%
BR.TOBig Rock Brewery Inc.
CA$0.67-1.47%
GCL.TOColabor Group Inc.
CA$0.04+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
INTCIntel
$114.68-0.05%
SPCEVirgin Galactic
$6.18+0.36%
FFord Motor Company
$17.44+0.05%
NOKNokia
$14.84-0.03%

Questions About EBM

What is the current price of Eastwood Bio-Medical Canada?

Eastwood Bio-Medical Canada is trading at CA$0.77 per share.

What is the 52-week range for Eastwood Bio-Medical Canada?

Over the past 52 weeks, Eastwood Bio-Medical Canada has traded between CA$0.30 and CA$1.10.

How much debt does Eastwood Bio-Medical Canada have?

As of the most recent reporting period, Eastwood Bio-Medical Canada reported total debt of CA$74.67K.

How much cash does Eastwood Bio-Medical Canada have on hand?

Eastwood Bio-Medical Canada reported CA$13.46K in cash and cash equivalents in its most recent financial results.

What is Eastwood Bio-Medical Canada’s dividend yield?

Eastwood Bio-Medical Canada does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.